Who is sponsoring NCT01615731?

NCT01615731 is sponsored by Stanford University.

What condition does NCT01615731 study?

NCT01615731 studies Abortion, Induced.

What drugs are being tested in NCT01615731?

Interventions: Mifepristone, Hygroscopic cervical dilators, Misoprostol, Intra-amniotic digoxin.

What is the status of NCT01615731?

NCT01615731 is currently COMPLETED.

Last reviewed 2024-01-19 · How we verify

Value of Mifepristone in Eliminating the Need for a Second Set of Osmotic Dilators Prior to Dilation and Evacuation Between 19-24 Weeks: A Randomized Trial

NCT01615731 NA COMPLETED Results posted

A common practice for preparation for surgical abortion after 19 weeks gestation is the placement of multiple sets of osmostic dilators 1-2 days prior to the procedure. The investigators aim to study the addition of mifepristone as an adjunct to cervical dilation prior to abortion between 19-24 weeks gestation, and its potential to minimize the number of painful procedures and time in clinic (or away from work/home) that multiple sets of dilators can require. The investigators hypothesize that one set of dilators with mifepristone will result in similar procedure times and decreased "total" time as two sets of dilators.

Details

Lead sponsor	Stanford University
Phase	NA
Status	COMPLETED
Enrolment	50
Start date	2012-05
Completion	2013-07

Conditions

Abortion, Induced

Interventions

Mifepristone
Hygroscopic cervical dilators
Misoprostol
Intra-amniotic digoxin

Primary outcomes

Procedure Time — Intraoperative Time
Measured as time from speculum insertion to removal
Total Procedure Time — Measured at clinic visits and on OR day, over a 3 day period

Countries

United States